Rafat abonour
WebDr. Rafat Abonour is a hematologist in Indianapolis, Indiana and is affiliated with multiple hospitals in the area, including Indiana University Health Medical Center and Indiana … WebDr. Rafat Abonour, MD is a hematology specialist in Indianapolis, IN. Dr. Abonour completed a residency at Sinai Samaritan Med Ctr. He currently practices at IU Simon Cancer Center …
Rafat abonour
Did you know?
WebDr. Rafat Abonour is a hematologist in Indianapolis, IN, and is affiliated with multiple hospitals including Eskenazi Health-Indianapolis. He has been in practice more than 20 years. 21+ Years of... WebApr 20, 2006 · Dr. Rafat Abonour has a medical practice at 10300 N Illinois St, Indianapolis, IN. Dr. Rafat Abonour specializes in hematology oncology and has over 39 years of …
WebMay 8, 2015 · Dr. Rafat Abonour, MD is a health care provider primarily located in Indianapolis, IN. His specialties include Oncologist/hematologist, Hematologist, Oncologist. Dr. Abonour is affiliated with IU Health Methodist/IU Health University, IU Health North and IU Health West. Featured Providers Near You Cleveland Clinic Dr. Yaser Al-Marrawi, MC WebJan 3, 2013 · Rafat Abonour, MD, a board-certified specialist in Internal Medicine and Hematology, is the Chief of the Multiple Myeloma Program at the Indiana University Melvin and Bren Simon Cancer Center. In addition, Dr. Abonour holds the position of Associate Dean for Clinical Research at the Indiana University Medical School.
WebRafat Abonour, MD Harry and Edith Gladstein Professor of Cancer Research Address Indiana Cancer Pavilion, Suite 446 535 Barnhill Dr RT 446 Indianapolis, IN 46202-5289 Bio I have … WebRafat Abonour, MD Simon Cancer Center Indiana University School of Medicine Indianapolis, IN, USA. Introduction: Novel therapies have improved the median overall survival (OS) for newly diagnosed multiple myeloma (NDMM). In an unselected population of NDMM patients, the estimated rates of 5-year OS were 77%, 53%, and 19% for revised international staging …
WebJan 24, 2014 · Dr. Rafat Abonour, MD, is a Hematology/Oncology specialist in Indianapolis, Indiana. He attended and graduated from medical school in 1984, having over 39 years of diverse experience, especially in Hematology/Oncology. He is affiliated with many hospitals including Indiana University Health, Indiana University Health Ball Memorial Hospital ...
Web1030 W Michigan St # C5226, Indianapolis, IN 46202. Icon Directions Right Arrow. Directions. Phone Icon. (317) 274-8157. corrugated open house signs remaxWebDr. Rafat Abonour specializes in Cancer Treatment for IUSCC Hematology Clinic. Dr. Abonour earned his medical degree at the University of Damascus. He then completed an … brawlhalla serverWebSep 18, 2024 · Dr. Rafat Abonour and his fellow riders catch their breath after the 2013 cycling event. Most men in their 50s don’t bike 200 miles during a weekend. Rafat Abonour, MD, is not most men. He’s on a mission. He’s passionate about finding a cure for multiple myeloma, an incurable but treatable blood cancer. Dr. brawlhallas instant aerialsWebDr. Rafat Abonour, MD Oncologist Hematologist Leave a review IUSCC Hematology Clinic - IU Health Simon Cancer Center 1030 W Michigan St 2nd Floor, Indianapolis, IN, 46202 … brawlhalla size on steamWebDr. Rafat Abonour earned his M.D. from the University of Damascus in 1983. He later joined the Indiana University School of Medicine (IUSM) faculty in 1995 as an assistant professor of medicine. He was promoted to associate professor of medicine, pathology, and laboratory medicine in 2001, associate dean for clinical research in 2005, and full ... brawlhalla smartphoneWebRafat Abonour, MD Simon Cancer Center Indiana University School of Medicine Indianapolis, IN, USA. Introduction: t(11;14) is a common cytogenetic abnormality found in ~15% of patients (pts) with MM.Although t(11;14) is historically associated with favorable or neutral outcomes in MM (Sawyer 2011; Moreau 2007), it has been associated with poor … brawlhalla shop codesWebRafat Abonour View Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent … brawlhalla slayer of the chosen